Demetrio Sharp Dimitri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Demetrio Sharp Dimitri has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Andrew Panakos
University of Miami Hospital and Clinics
1 shared publication- Anna V. Subramaniam
Division of Cardiology, Department of Medicine, University of Washington, Seattle, Washington
1 shared publication Carlos Alfonso
University of Miami, Miller School of Medicine
1 shared publicationChristine J. Chung
Division of Cardiology, Department of Medicine, University of Washington, Seattle, Washington
1 shared publication- Creighton W. Don
The University of Washington Medical Center; Veterans Affairs Puget Sound Hospital, Department of Medicine
1 shared publication David Elison
Division of Cardiology, Department of Medicine, University of Washington, Seattle, Washington
1 shared publication
Latest Publications
- Open Access
- 13 September 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (18) , 7103
Athletes with Implantable Cardioverter-Defibrillators: A Practical Framework for Device Selection, Programming, and Return-to-Sport Risk Mitigation
Implantable cardioverter-defibrillators (ICDs) were historically viewed as a barrier to vigorous or competitive sport participation, based on theoretical concerns about arrhythmia induction, inappropriate shocks, device damage, and shock-related injury during activity. Contemporary registry data have reframed this paradigm, demonstrating that selected athletes with ICDs can participate in organized sport without the catastrophic outcomes once feared, although these data remain reassuring rather than definitive given selection bias and underrepresentation of high-consequence sports. This review synthesizes contemporary athlete-specific registry data and broader randomized device and programming evidence, alongside current guideline recommendations, to provide a practical framework for the care of athletes with ICDs, addressing indications, which should remain diagnosis-driven rather than sport-driven; device selection, weighing transvenous, subcutaneous, and extravascular platforms against an athlete’s pacing needs, anatomy, and sport-specific trauma risk; and exercise-informed device programming. We then present a longitudinal framework integrating clinical readiness, device readiness, sport-specific risk, emergency preparedness, shared decision-making, and reassessment after clinical or sporting changes. Special populations and priorities for future research are also discussed. Rather than a binary clearance decision, modern management of athletes with ICDs requires an individualized, longitudinally reassessed approach to risk.
- 13 September 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (18) , 7103
Open AccessAthletes with Implantable Cardioverter-Defibrillators: A Practical Framework for Device Selection, Programming, and Return-to-Sport Risk Mitigation
Implantable cardioverter-defibrillators (ICDs) were historically viewed as a barrier to vigorous or competitive sport participation, based on theoretical concerns about arrhythmia induction, inappropriate shocks, device damage, and shock-related injury during activity. Contemporary registry data have reframed this paradigm, demonstrating that selected athletes with ICDs can participate in organized sport without the catastrophic outcomes once feared, although these data remain reassuring rather than definitive given selection bias and underrepresentation of high-consequence sports. This review synthesizes contemporary athlete-specific registry data and broader randomized device and programming evidence, alongside current guideline recommendations, to provide a practical framework for the care of athletes with ICDs, addressing indications, which should remain diagnosis-driven rather than sport-driven; device selection, weighing transvenous, subcutaneous, and extravascular platforms against an athlete’s pacing needs, anatomy, and sport-specific trauma risk; and exercise-informed device programming. We then present a longitudinal framework integrating clinical readiness, device readiness, sport-specific risk, emergency preparedness, shared decision-making, and reassessment after clinical or sporting changes. Special populations and priorities for future research are also discussed. Rather than a binary clearance decision, modern management of athletes with ICDs requires an individualized, longitudinally reassessed approach to risk.
- 25 July 2026
- Published by Elsevier in The American Journal of Cardiology
- Vol. 276, 54-57
Diagnosis, Referral, Treatment Delays, and Outcomes in Veterans Affairs Patients Undergoing TAVR
- 25 July 2026
- Published by Elsevier in The American Journal of Cardiology
- Vol. 276, 54-57
Diagnosis, Referral, Treatment Delays, and Outcomes in Veterans Affairs Patients Undergoing TAVR
- Open Access
- 5 March 2025
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 4 (4) , 102583
Novel Use of MitraClip for Treatment of Severe Aortic Regurgitation
- 5 March 2025
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 4 (4) , 102583
Open AccessNovel Use of MitraClip for Treatment of Severe Aortic Regurgitation
- Open Access
- 12 January 2021
- Published by Wiley
ASYMPTOMATIC ANOMALOUS LEFT CORONARY ARTERY FROM THE PULMONARY ARTERY (ALCAPA) IN AN ADULT.
We describe a patient in whom this anomaly was diagnosed during cardiac catheterization for evaluation of progressive shortness of breath and mild to moderate mitral regurgitation founded on a transthoracic echocardiogram.A 58-year-old hypertensive female was evaluated for progressive shortness of breath. Her physical examination showed a regular heart rate and rhythm, with normal heart sounds with a holosystolic systolic murmur on the 4th intercostal midclavicular line on auscultation. Electrocardiography showed normal sinus rhythm and criteria and possible left ventricular hypertrophy. Stress Echocardiogram showed with no evidence of ischemia preserved left ventricular function with an ejection fraction of 55-60%, with mild to moderate mitral regurgitation. Patient underwent a coronary catheterization for persistent shortness of breath which indicated no evidence of obstructive coronary disease, normal left ventricular function with mild to moderate mitral insufficiency. Angiography of the right coronary artery showed a very large and tortuous artery that collateralizes into the left main system and supplies the entire left coronary artery system. The left main coronary origin was from the pulmonary artery. CTA confirmed the same findings. The recommendations between cardiology and cardiothoracic surgery were to maximize medical therapy and follow up due to lack of myocardial ischemia or severe valvular disease. Currently there are no guidelines or gold standard management for patients with adult form of ALCAPA that present without ischemic burden or for patients with the disease that present asymptomatic with significant coronary collateralization.
- 12 January 2021
- Published by Wiley
Open AccessASYMPTOMATIC ANOMALOUS LEFT CORONARY ARTERY FROM THE PULMONARY ARTERY (ALCAPA) IN AN ADULT.
We describe a patient in whom this anomaly was diagnosed during cardiac catheterization for evaluation of progressive shortness of breath and mild to moderate mitral regurgitation founded on a transthoracic echocardiogram.A 58-year-old hypertensive female was evaluated for progressive shortness of breath. Her physical examination showed a regular heart rate and rhythm, with normal heart sounds with a holosystolic systolic murmur on the 4th intercostal midclavicular line on auscultation. Electrocardiography showed normal sinus rhythm and criteria and possible left ventricular hypertrophy. Stress Echocardiogram showed with no evidence of ischemia preserved left ventricular function with an ejection fraction of 55-60%, with mild to moderate mitral regurgitation. Patient underwent a coronary catheterization for persistent shortness of breath which indicated no evidence of obstructive coronary disease, normal left ventricular function with mild to moderate mitral insufficiency. Angiography of the right coronary artery showed a very large and tortuous artery that collateralizes into the left main system and supplies the entire left coronary artery system. The left main coronary origin was from the pulmonary artery. CTA confirmed the same findings. The recommendations between cardiology and cardiothoracic surgery were to maximize medical therapy and follow up due to lack of myocardial ischemia or severe valvular disease. Currently there are no guidelines or gold standard management for patients with adult form of ALCAPA that present without ischemic burden or for patients with the disease that present asymptomatic with significant coronary collateralization.